About: Extracorporeal Blood Purification and Organ Support in the Critically Ill Patient during COVID-19 Pandemic: Expert Review and Recommendation

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Extracorporeal Blood Purification and Organ Support in the Critically Ill Patient during COVID-19 Pandemic: Expert Review and Recommendation Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Extracorporeal Blood Purification and Organ Support in the Critically Ill Patient during COVID-19 Pandemic: Expert Review and Recommendation
Creator	Reis, Thiago Ronco, Claudio Bagshaw, Sean Bellomo, Rinaldo Clark, William Husain-Syed, Faeq Kellum, John Ostermann, Marlies Ricci, Zaccaria Rimmelé, Thomas
source	Medline; PMC
abstract	Critically ill COVID-19 patients are generally admitted to the ICU for respiratory insufficiency which can evolve into a multiple-organ dysfunction syndrome requiring extracorporeal organ support. Ongoing advances in technology and science and progress in information technology support the development of integrated multi-organ support platforms for personalized treatment according to the changing needs of the patient. Based on pathophysiological derangements observed in COVID-19 patients, a rationale emerges for sequential extracorporeal therapies designed to remove inflammatory mediators and support different organ systems. In the absence of vaccines or direct therapy for COVID-19, extracorporeal therapies could represent an option to prevent organ failure and improve survival. The enormous demand in care for COVID-19 patients requires an immediate response from the scientific community. Thus, a detailed review of the available technology is provided by experts followed by a series of recommendation based on current experience and opinions, while waiting for generation of robust evidence from trials.
has issue date	2020-05-26(xsd:dateTime)
bibo:doi	10.1159/000508125
bibo:pmid	32454500
has license	no-cc
sha1sum (hex)	b8da6dbe10e14c732d2854d2077e8dd22886f804
schema:url	https://doi.org/10.1159/000508125
resource representing a document's title	Extracorporeal Blood Purification and Organ Support in the Critically Ill Patient during COVID-19 Pandemic: Expert Review and Recommendation
has PubMed Central identifier	PMC7270067
has PubMed identifier	32454500
schema:publication	Blood Purif
resource representing a document's body	covid:b8da6dbe10e14c732d2854d2077e8dd22886f804#body_text
is schema:about of	named entity 'personalized treatment' named entity 'generally' named entity 'Critically' named entity 'Critically' named entity 'EVOLVE' named entity 'RESPIRATORY INSUFFICIENCY' named entity 'PERSONALIZED' named entity 'support' named entity 'organ support' named entity 'technology' named entity 'Review' named entity 'Extracorporeal' named entity 'organ support' named entity 'organ support' named entity 'ICU' named entity 'hemoperfusion' named entity 'EUPHRATES' named entity 'COVID-19' named entity 'HLA-DR' named entity 'anticoagulation' named entity 'RCT' named entity 'IL-6' named entity 'hypoxemic' named entity 'tidal volume' named entity 'capillary leak syndrome' named entity 'adverse effects' named entity 'blood flow' named entity 'extracorporeal' named entity 'intensive care units' named entity 'Kidney' named entity 'kidney function' named entity 'COVID-19' named entity 'IL-6' named entity 'membrane oxygenator' named entity 'hypercapnic' named entity 'procalcitonin' named entity 'biocompatible' named entity 'plasma' named entity 'cytokine' named entity 'critically ill patients' named entity 'endotoxin' named entity 'COVID-19' named entity 'bile acids' named entity 'sorbent' named entity 'kidney dysfunction' named entity 'cytokines' named entity 'adsorption' named entity 'organ' named entity 'ARDS' named entity 'cytokine' named entity 'adsorption' named entity 'thrombophilia' named entity 'hemoperfusion' named entity 'COVID-19 infection' named entity 'organ' named entity 'vasopressors' named entity 'hypotension' named entity 'clinical trials' named entity 'COVID-19 infection' named entity 'intensive care' named entity 'pneumonia' named entity 'pathogen-associated molecular patterns' named entity 'arterial pressure' named entity 'vaccine' named entity 'bacterial sepsis' named entity 'artificial organ' named entity 'COVID-19' named entity 'endotoxin' named entity 'Fresenius Medical Care' named entity 'hemoperfusion' named entity 'immune response' named entity 'sepsis'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software